MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Public ClinicalTrials.gov record NCT00166270. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Post Approval Study: MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a prospective, nonrandomized, multi-center study to evaluate the safety and effectiveness of ExAblate in the treatment of uterine fibroids. All patients will be treated and then followed for 36 months to evaluate the change in their fibroid symptoms.
Study identification
- NCT ID
- NCT00166270
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 70 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2004
- Primary completion
- Mar 31, 2006
- Completion
- Dec 31, 2008
- Last update posted
- Jul 8, 2018
2005 – 2009
United States locations
- U.S. sites
- 6
- U.S. states
- 5
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Radnet Management | Los Angeles | California | 90025 | — |
| University MRI | Boca Raton | Florida | 33431 | — |
| Brigham & Women's Hospital | Boston | Massachusetts | 02115 | — |
| Lahey Clinic | Burlington | Massachusetts | 01805 | — |
| Virtua | Voorhees Township | New Jersey | 08043 | — |
| North Texas Uterine Fibroid Institute | Plano | Texas | 75093 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Uterine Fibroids trials
Other public records listing Uterine Fibroids. Sorted by last update posted; newest first. Not a recommendation.
- NCT02100904: Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry Active, not recruiting
- NCT07501676: Transmucosal Uterosacral Electrical Stimulation for Pelvic Pain Relief Not yet recruiting
- NCT04126824: Effect of Addition of Steroids on Duration of Analgesia Active, not recruiting
- NCT07078682: An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms Recruiting
- NCT05862272: A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00166270, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 8, 2018 · Synced Sep 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00166270 live on ClinicalTrials.gov.